Bill
HR 661
The MIRACLE Medical Technology Act boosts U.S.-Israel collaboration in medical tech, fostering research and innovation to improve healthcare solutions and patient outcomes.
The MIRACLE Medical Technology Act of 2025 (HR 661) is a legislative proposal aimed at enhancing collaboration between the United States and Israel in the field of medical technology. Introduced on January 23, 2025, the bill seeks to maximize research advancements and foster leadership in emerging medical technologies.
The primary goal of the MIRACLE Medical Technology Act is to:
- Strengthen the partnership between the U.S. and Israel in medical technology research and development.
- Promote innovation and collaboration that can lead to breakthroughs in healthcare solutions.
While the full text of the bill has not been detailed in the provided information, the title suggests several potential areas of focus:
- Research Collaboration: The bill likely includes provisions for joint research initiatives between U.S. and Israeli institutions, potentially involving funding mechanisms or grants.
- Leadership Development: It may aim to establish programs that enhance leadership skills in emerging medical technologies, possibly through training or educational exchanges.
- Emerging Technologies: The act could prioritize specific areas of medical technology that are considered emerging or critical, such as telemedicine, biotechnology, or digital health solutions.
The bill is expected to impact:
- Research Institutions: Universities and research facilities in both the U.S. and Israel that focus on medical technology.
- Healthcare Providers: Hospitals and clinics that may benefit from new technologies developed through collaborative efforts.
- Patients: Individuals who could gain access to innovative medical treatments and technologies resulting from this collaboration.
The MIRACLE Medical Technology Act of 2025 represents a strategic initiative to enhance U.S.-Israel collaboration in medical technology. By fostering research and leadership in this critical field, the bill aims to drive innovation that could significantly benefit healthcare systems and patient outcomes in both nations. As the bill progresses through the legislative process, further details on specific provisions and funding mechanisms are anticipated.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
